Welcome to our dedicated page for Dynatronics news (Ticker: DYNT), a resource for investors and traders seeking the latest updates and insights on Dynatronics stock.
Dynatronics Corporation news has centered on the company's historical role as a manufacturer of athletic training, physical therapy, rehabilitation, pain management, and restorative medical products. Coverage has included quarterly financial results, demand trends in rehabilitation products, operating-cost and margin commentary, product-line additions such as Timber, Titan Premier, and Forged, and distribution to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals.
Recurring updates also cover Dynatronics' brand portfolio, including Bird & Cronin, Solaris, Hausmann, Physician's Choice, and PROTEAM, as well as board appointments, capital and credit-line disclosures, and the company's transition from Nasdaq trading to OTCQB quotation.
Dynatronics (NASDAQ: DYNT) announced its transition to the OTC Markets Group due to noncompliance with Nasdaq's minimum bid price requirement. The company received notice of impending delisting from Nasdaq effective July 9, 2024. Consequently, Dynatronics' common stock will be quoted on the OTCQB Venture Market immediately following the delisting. The ticker symbol and CUSIP will remain unchanged, and shareholders need not take any action. Despite the transition, Dynatronics will continue its business operations and remain a reporting company under the Securities Exchange Act of 1934.
Dynatronics , a leading manufacturer of athletic training, physical therapy, and rehabilitation products, reported financial results for its third quarter of fiscal year 2024. The CEO highlighted progress in sales goals and positive EBITDA. New product lines were introduced to enhance sales. Key financial results include total net sales of $7.7 million, a gross profit margin of 23.7%, and a net loss attributable to common stockholders of $0.9 million. The company provided guidance for fiscal year 2024, estimating net revenue to be $32.5 million to $34 million, with ongoing volatility expected due to economic challenges. Dynatronics will hold a conference call to review its third quarter results.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.